GREENWICH, CT, March 13, 2017 /CNW/ - Aptuit, LLC today announced that the company has been selected as a winner of four Contract Manufacturer Organization (CMO) Leadership Awards by Life Science Leader magazine. Aptuit was selected from a survey of pharma and biopharma companies who had outsourced projects within the past 18 months. Customers judge CMO winners as either exceeding expectations or as top performers.
Aptuit was named as a winner in four categories. From the survey participants who worked for Big Pharma, Aptuit was awarded CMO Leadership Awards in Expertise, Quality, and Compatibility. Aptuit was also recognized for exceeding expectations in the award category of Expertise when responses were combined from survey participants from both Big and Small Pharma.
Henning Steinhagen, Executive VP, Drug Discovery & Development, Aptuit, commented, "These awards demonstrate that our customers recognize and value the depth of experience of our scientists and the high quality of our operations. Aptuit differentiates by combining large pharma expertise and capabilities with the flexible cost effective approach of the only Partner Research Organization. We are truly honored to receive these awards as they come directly from the feedback of real customers."
"Each year, the CMO Leadership Awards recognize the success that individual drug development and manufacturing organizations have in serving the needs of their biotechnology and pharmaceutical customers and partners," says Louis Garguilo, Executive Editor, Life Science Leader magazine and OutsourcedPharma.com. "Recipients are evaluated by the executives and managers at the sponsors the CMOs have worked, in the six critical categories of capabilities, compatibility, expertise, quality, reliability and development. An award in any of these categories adds to the distinction and reputation of CMOs within the greater drug discovery, development, manufacturing and marketing industries."
"Industry Standard Research is honored to conduct the research for Life Science Leader's CMO Awards. ISR's stringent screening processes and the high caliber of qualification required to participate in our contract manufacturing benchmarking research means that real customers provide experiential feedback on their involvement with contract suppliers over the past 18 months. This enables users of ISR's research to make confident business decisions based on the experiences of their industry peers," said Andrew Schafer, President of Industry Standard Research.
Aptuit provides the most complete set of integrated early discovery to mid-phase drug development services in the pharmaceutical industry including Drug Design & Discovery, API Development and Manufacture, Solid State Chemistry, CMC, Preclinical and IND enabling GLP/GMP programs. Fully integrated drug discovery & development services are available from our facilities in the UK, Italy, and Switzerland.
Aptuit Holdings, LLC is partnered with Welsh, Carson, and Anderson & Stowe, one of the world's leading private equity investors.
For more information, please visit http://www.aptuit.com
SOURCE Aptuit Holdings, LLC